Explore the full management transaction log of Xbrane Biopharma AB, a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Xbrane Biopharma AB has recorded 1 public disclosures. Market capitalisation: €227.7m. The latest transaction was filed on 28 October 2025 — Sale. Among the most active insiders: Siavash Bashiri. Every trade is openly available.